NDC 0409-7620
Heparin Sodium 200 [USP'U] per 100 mL injection, solution
On the label: Hospira, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Hospira, Inc. | Rocky Mount, NC, United States | Makes it, tests it, packages it and labels it | No problems foundFeb 7, 2025 · 11 inspections, 3 with FDA action |
| Hospira, Inc. | McPherson, KS, United States | Tests it | Problems found, fixed voluntarilyJan 17, 2025 · 16 inspections, 2 with FDA action |
Recalls
- Dec 29, 2022 · Class II · Pfizer Inc.
Lack of assurance of sterility: Bags have the potential to leak.
Lots: Lot: 5935283, Exp. 12/01/2023 - Sep 11, 2014 · Class I · Hospira Inc.
Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container.
Lots: Lot #: 41-046-JT, Exp 11/01/2015 - Jan 9, 2014 · Class II · Hospira Inc.
Lack of Assurance of Sterility; potential leakage from administrative port.
Lots: Lot #: 26-125-JT, Exp: 8/14
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Heparin: every company that makes it
- Form
- injection, solution
- Strength
- 200 [USP'U] per 100 mL
- Approval
- NDA NDA018916
- On the market since
- Mar 31, 2005
- Package NDCs
0409-7620-030409-7620-130409-7620-490409-7620-59- Official label
- DailyMed (National Library of Medicine), updated May 12, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?